Department of
Work from the lab of Jeffery Gordon, MD was recently featured in Science as a runner up for Breakthrough of The Year. This title is awarded yearly by the journal Science to recognize significant discoveries or developments in scientific research. The journal highlighted work by Arjun Raman, MD, PhD (PGY3 Clinical Pathology Resident) and others […]
In the Department of Pathology and Immunology, we strongly support our trainees and any opportunities that come along to further their knowledge and experiences. Recently some of our trainees had the opportunity to attend the AABB and AMP conferences.
Over $3 million in grants awarded to faculty in Pathology & Immunology. GRANTS Cole John Ferguson, MD, Instructor in Pathology and Immunology, received a five-year $164,015 grant from The National Institutes of Health, entitled “Ubiquitin Signaling in Epigenetic Regulation of Neuronal Development”. Chang Liu, MD, PhD, Assistant Professor of Pathology and Immunology, received a two-year […]
Jonathan Kipnis, PhD, an internationally recognized scientific leader in how the nervous and immune systems interact in neurodegenerative, neuroinflammatory and neurodevelopmental disorders, has been named a BJC Investigator at Washington University School of Medicine in St. Louis. He will join the Department of Pathology and Immunology, with secondary appointments in the neurology, neuroscience and neurosurgery departments.
Cancer immunotherapy drugs trigger the body’s immune system to attack tumors and have revolutionized the treatment of certain cancers, such as lymphoma, lung cancer and melanoma. Yet, while some patients respond well to the drugs, others don’t respond at all. Cancer immunologists want to change that.
Researchers have found an antibody that protects mice against a wide range of lethal influenza viruses, according to a study from Washington University School of Medicine in St. Louis, Icahn School of Medicine at Mount Sinai in New York City, and Scripps Research in La Jolla, Calif. The antibody could serve as a template to […]
A number of Pathology & Immunology trainees and a faculty member had the amazing opportunity to present research at this year’s annual meeting of the American Society of Dermatopathology. The meeting was held October 17-20 in San Diego, CA. The experience, according to one trainee, was very educational, with lots of feedback on their work […]
A specific microbe can break down a chemical common in manufactured foods
The College of American Pathologists Annual Meeting (CAP19) recently took place in Orlando, Florida and a number of faculty and trainees from the Pathology & Immunology department were in attendance.
Obesity expert Jonathan R. Brestoff, MD, PhD, and regenerative medicine specialist Thorold Theunissen, PhD, both of Washington University School of Medicine in St. Louis, have received High-Risk, High-Reward Research awards from the National Institutes of Health (NIH).
Ronald Jackups, MD, PhD, will receive the AABB President’s Award at the 2019 AABB Annual Meeting on October 19.
Certain human gut microbes with links to health thrive when fed specific types of ingredients in dietary fibers, according to a new study from Washington University School of Medicine in St. Louis.
At the beginning of August, members from the Department of Pathology & Immunology attended the 71st AACC Annual Scientific Meeting & Clinical Lab Expo in Anaheim, CA.
Over $800,000 in grants awarded to faculty in Pathology & Immunology.
A new type of therapeutic food, specifically designed to repair the gut microbiomes of malnourished children, is superior to standard therapy in an initial clinical trial conducted in Bangladesh.
Eight trainees were awarded the Paul E. Strandjord Young Investigator Award, including Adam Bailey and Jonathan Brestoff who were recognized for their outstanding presentations.
The Department of Pathology & Immunology hosted its annual Trainee Research Day which celebrates research by residents and clinical fellows. It featured presentations both oral and poster from trainees.
Over $8 million in grants were awarded to faculty in Pathology & Immunology.
Two physician-scientists at Washington University School of Medicine in St. Louis are among the 100 new members and 25 foreign associates elected to the National Academy of Sciences this year.
Almost $7 million in grants awarded to faculty in Pathology & Immunology Paul Allen, PhD, Robert L. Kroc Professor of Pathology and Immunology and Interim Division Chief, Immunobiology, received five-year $2,349,441grant from The National Institutes of Health / National Institute of Allergy and Infectious Diseases, entitled “Strength of TCR:self-pMHC Interactions in the Periphery Instructs CD4+ […]
Probiotics – which are living bacteria taken to promote digestive health – can evolve once inside the body and have the potential to become less effective and sometimes even harmful, according to a new study from Washington University School of Medicine in St. Louis.
Eynav Klechevsky, assistant professor of pathology and immunology and Amit Pathak assistant professor of mechanical engineering & material science in the McKelvey School of Engineering at Washington University were awarded a three-year, $610,000 Trailblazer Award, from the National Institutes of Health’s National Institute of Biomedical Imaging and Bioengineering. This award provides funding to continue their […]
Study finds mimic for BRCA genes that could be targeted to improve treatment.
Close to $9 million in grants awarded to faculty in Pathology & Immunology Gautam Dantas, PhD, Professor of Pathology and Immunology, of Biomedical Engineering, and of Molecular Microbiology, received a one-year $486,849 contract from Centers for Disease Control and Prevention (CDC) entitled “Impact of Early Life Antibiotic Treatment in Preterm Infants on Subsequent MDRO Colonization […]
The National Center for Complementary and Integrative Health of the National Institutes of Health (NIH) has awarded a $3.5 million grant to study how live bacteria can be used for drug delivery to Gautam Dantas, professor of pathology and immunology, and Thaddeus Stappenbeck, the Conan Professor of Laboratory and Genomic Medicine, both at the School of Medicine, and Tae Seok Moon, associate […]
Washington University in St. Louis’ newly launched Cordell Institute for Policy in Medicine & Law has signed on as one of the early signatories of French President Emmanuel Macron’s “Paris Call for Trust and Security in Cyberspace,” announced Nov. 12 as part of the peace forum commemorating 100 years since the ending of World War I.
People with autoimmune diseases such as psoriasis, lupus and rheumatoid arthritis are at high risk of developing cardiovascular disease, even though none of these conditions seem to target the cardiovascular system directly. Now, researchers at Washington University School of Medicine in St. Louis believe they have begun to understand the link between the two.
Over $7 million in grants awarded to faculty in Pathology & Immunology Gautam Dantas, PhD, Professor of Pathology and Immunology, of Biomedical Engineering, and of Molecular Microbiology, received a five-year $3,484,069 grant from the National Institutes of Health, entitled “Tunable Therapeutic Modulation of the Gut Microbiome by Engineered Probiotics”. Paul Li-Hao Huang, PhD, Instructor in […]
A DNA-based analysis of blood cells soon after a stem cell transplant can predict likelihood of disease recurrence in patients with myelodysplastic syndrome (MDS), a group of cancerous disorders characterized by dysfunctional blood cells, according to new research at Washington University School of Medicine in St. Louis. Such a practice could help doctors identify patients […]
Jeffrey I. Gordon, MD, of Washington University School of Medicine in St. Louis, has received a 2018 Luminary Award from the Precision Medicine World Conference. He is being honored for his pioneering work in founding the field of gut microbiome research and for fundamentally altering the understanding of the origins of human health and disease, especially as […]
Over $500,000 in grants awarded to faculty in Pathology & Immunology Takeshi Egawa, M.D., Ph.D., Associate Professor of Pathology and Immunology, received a two-year $155,875 grant from the National Institutes of Health, entitled “The Role of TH1 CD4 T Cells in Control of Viral Infection. Ali Ellebedy, Ph.D., Assistant Professor, Pathology & Immunology, received a […]
Each year, Washington University School of Medicine faculty members have the opportunity to nominate their peers for Distinguished Faculty Awards.
The faculty in the Division of Laboratory and Genomic Medicine (LGM) serve as medical directors for the clinical laboratories at Barnes Jewish Hospital (BJH); however, they also provide medical direction and clinical consulting services to hospital laboratories in the St. Louis region and beyond.
Virology testing previously performed at the St. Louis Children’s Hospital (SLCH) Virology Laboratory officially transitioned to the Barnes Jewish Hospital (BJH) Molecular Infectious Disease Laboratory (MIDL) on January 29, 2018.
Beginning May 1st, the Core Lab will transition from the current ELISA anti-PF4/heparin antibody test to a latex immunoturbidimetric assay (LIA) performed on the TOPS coagulation analyzer. The test will be available 24/7 with an in-lab turnaround time of 1-2 hours. Laboratory comparisons to SRA send out results show a sensitivity of 100% and a […]
Infections due to antibiotic resistant bacteria are a global public health crisis. To help combat infections with multi-drug resistant bacteria, there has been a recent surge in the development of antimicrobial agents. The Barnes Jewish Hospital Microbiology Laboratory is now able to perform susceptibility testing for a number of these new antibiotics. Information regarding this […]
Stephen Roper joined Washington University as Assistant Professor of Pathology and Immunology and Assistant Director, Pediatric Laboratory Services in the Division of Laboratory and Genomic Medicine in August, 2017. He is NRCC (National Registry Certified Chemists) certified in Clinical Chemistry. Dr. Roper obtained his BS and MS at Texas Tech University and his PhD at […]
Jeffrey I. Gordon, MD, of Washington University School of Medicine in St. Louis, has received the 2018 Copley Medal from the Royal Society in Britain. He is being honored for his studies of human gut microbial communities, which have led to a fundamental shift in the way scientists understand the relationship between microbes, health and […]
As highlighted in BJC Today in December 2017, the Bone Marrow and Stem Cell Transplant Program met a milestone of 7,500 transplants!
Effective May 1st, Insulin and C-peptide and Dehydroepiandrosterone sulfate (DHEAS) (effective May 1st) will no longer be sent to Mayo Laboratories.
Gautam Dantas, PhD is senior author on a study showing antibiotics in the environment contribute to drug resistance.
A study lead by Maxim Artyomov, PhD shows that a compound derived from the body’s own immune cells can treat psoriasis in mice and holds promise for other autoimmune diseases.
Virus infects rare intestinal cells in mice; findings point to therapeutic strategy
Senior author Michael Diamond, MD, PhD reports that killing gut bacteria with drugs weakens the immune response
Advancements in genetic testing are promising, and for rare diseases, patient education, coupled with the right laboratory test, are keys to diagnosis and management.
Faculty members nominate peers to recognize their colleagues’ wide-ranging achievements, talents and dedication.
Pledges commitment to basic science research
The Olin Fellowships recognize superior accomplishments in biomedical research by doctoral students at Washington University. Josh Brickner, from the laboratory of Nima Mosammaparast, PhD, is one of five students selected for the 2017-2018 honor. Josh Brickner studies the mechanism by which the ASCC-ALKBH3 repair complex is recruited to sites of alkylation damage. He found that […]
Two projects from Pathology & Immunology were selected this year to receive funding though the Leadership in Entrepreneurial Acceleration Program (LEAP). They include: Targeting type III interferon for the treatment of multiple sclerosis This project is a potential new biomarker of progressive forms of multiple sclerosis (MS) that, when targeted, can prevent axonal injury and […]
Honored for expertise in infectious diseases, microbiology